Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.

Crassard N, Hadden H, Pondarré C, Hadden R, Galambrun C, Piens MA, Pracros JP, Souillet G, Basset T, Berthier JC, Philippe N, Bertrand Y.

Transpl Infect Dis. 2008 Jun;10(3):177-83. doi: 10.1111/j.1399-3062.2008.00304.x. Epub 2008 Mar 4.

PMID:
18331389
2.

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.

Grow WB, Moreb JS, Roque D, Manion K, Leather H, Reddy V, Khan SA, Finiewicz KJ, Nguyen H, Clancy CJ, Mehta PS, Wingard JR.

Bone Marrow Transplant. 2002 Jan;29(1):15-9.

3.

Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.

El-Cheikh J, Castagna L, Wang L, Esterni B, Faucher C, Fürst S, Pierre B, Mohty M, Blaise D.

Leuk Lymphoma. 2010 Sep;51(9):1705-10. doi: 10.3109/10428194.2010.500433.

PMID:
20629522
4.

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.

Cordonnier C, Ribaud P, Herbrecht R, Milpied N, Valteau-Couanet D, Morgan C, Wade A; Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Clin Infect Dis. 2006 Apr 1;42(7):955-63. Epub 2006 Feb 22.

PMID:
16511759
5.

Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.

Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S, Ibatici A, Del Bono V, Bacigalupo A, Viscoli C.

Bone Marrow Transplant. 2009 Sep;44(6):361-70. doi: 10.1038/bmt.2009.39. Epub 2009 Mar 23.

PMID:
19308042
6.

Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.

Rubio PM, Sevilla J, González-Vicent M, Lassaletta A, Cuenca-Estrella M, Díaz MA, Riesco S, Madero L.

J Pediatr Hematol Oncol. 2009 Sep;31(9):642-6. doi: 10.1097/MPH.0b013e3181acd956.

PMID:
19684521
8.

Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen.

Kojima R, Kami M, Nannya Y, Kusumi E, Sakai M, Tanaka Y, Kanda Y, Mori S, Chiba S, Miyakoshi S, Tajima K, Hirai H, Taniguchi S, Sakamaki H, Takaue Y.

Biol Blood Marrow Transplant. 2004 Sep;10(9):645-52.

9.

Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergillosis.

Sevilla J, Hernandez-Maraver D, Aguado MJ, Ojeda E, Morado M, Hernandez-Navarro F.

Ann Hematol. 2001 Aug;80(8):456-9.

PMID:
11563590
11.

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.

Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M, Diekema DJ.

Diagn Microbiol Infect Dis. 2006 Jul;55(3):209-12. Epub 2006 Apr 19.

PMID:
16626917
12.

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.

Sinkó J, Csomor J, Nikolova R, Lueff S, Kriván G, Reményi P, Bátai A, Masszi T.

Transpl Infect Dis. 2008 Apr;10(2):106-9. Epub 2007 Jul 1.

PMID:
17605727
13.

Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.

Oshima K, Kanda Y, Asano-Mori Y, Nishimoto N, Arai S, Nagai S, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M.

J Antimicrob Chemother. 2007 Aug;60(2):350-5. Epub 2007 Jun 21.

PMID:
17584800
14.

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.

Post MJ, Lass-Floerl C, Gastl G, Nachbaur D.

Transpl Infect Dis. 2007 Sep;9(3):189-95. Epub 2007 May 19.

PMID:
17511828
15.

A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.

Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.

Bone Marrow Transplant. 2006 Jul;38(2):127-34. Epub 2006 Jun 5.

PMID:
16751782
16.

Invasive aspergillosis in a paediatric haematology department: a 15-year review.

Crassard N, Hadden H, Piens MA, Pondarré C, Hadden R, Galambrun C, Pracros JP, Souillet G, Basset T, Berthier JC, Philippe N, Bertrand Y.

Mycoses. 2008 Mar;51(2):109-16. doi: 10.1111/j.1439-0507.2007.01449.x.

PMID:
18254746
17.

Invasive aspergillosis in hematopoietic stem cell transplant recipients: a retrospective analysis.

Carvalho-Dias VM, Sola CB, Cunha CA, Shimakura SE, Pasquini R, Queiroz-Telles Fd.

Braz J Infect Dis. 2008 Oct;12(5):385-9.

18.

Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation.

Mihu CN, King E, Yossepovitch O, Taur Y, Jakubowski A, Pamer E, Papanicolaou GA.

Transpl Infect Dis. 2008 Jun;10(3):162-7. Epub 2007 Jul 27.

PMID:
17662036
19.

Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients.

Jantunen E, Nihtinen A, Anttila VJ.

Transpl Infect Dis. 2008 Jun;10(3):156-61. doi: 10.1111/j.1399-3062.2008.00301.x. Epub 2008 Feb 11. Review.

PMID:
18266785
20.

Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study.

Rovira M, Jimenéz M, De La Bellacasa JP, Mensa J, Rafel M, Ortega M, Almela M, Martínez C, Fernández-Avilés F, Martínez JA, Urbano-Ispizua A, Carreras E, Montserrat E.

Transplantation. 2004 Apr 27;77(8):1260-4.

PMID:
15114095

Supplemental Content

Support Center